Npc1 Acting in Neurons and Glia Is Essential for the Formation and Maintenance of CNS Myelin

English version České info

Cholesterol availability is rate-limiting for myelination, and prior studies have established the importance of cholesterol synthesis by oligodendrocytes for normal CNS myelination. However, the contribution of cholesterol uptake through the endocytic pathway has not been fully explored. To address this question, we used mice with a conditional null allele of the Npc1 gene, which encodes a transmembrane protein critical for mobilizing cholesterol from the endolysosomal system. Loss of function mutations in the human NPC1 gene cause Niemann-Pick type C disease, a childhood-onset neurodegenerative disorder in which intracellular lipid accumulation, abnormally swollen axons, and neuron loss underlie the occurrence of early death. Both NPC patients and Npc1 null mice exhibit myelin defects indicative of dysmyelination, although the mechanisms underlying this defect are incompletely understood. Here we use temporal and cell-type-specific gene deletion in order to define effects on CNS myelination. Our results unexpectedly show that deletion of Npc1 in neurons alone leads to an arrest of oligodendrocyte maturation and to subsequent failure of myelin formation. This defect is associated with decreased activation of Fyn kinase, an integrator of axon-glial signals that normally promotes myelination. Furthermore, we show that deletion of Npc1 in oligodendrocytes results in delayed myelination at early postnatal days. Aged, oligodendocyte-specific null mutants also exhibit late stage loss of myelin proteins, followed by secondary Purkinje neuron degeneration. These data demonstrate that lipid uptake and intracellular transport by neurons and oligodendrocytes through an Npc1-dependent pathway is required for both the formation and maintenance of CNS myelin.

Vyšlo v časopise: Npc1 Acting in Neurons and Glia Is Essential for the Formation and Maintenance of CNS Myelin. PLoS Genet 9(4): e32767. doi:10.1371/journal.pgen.1003462
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1003462

Souhrn

Zdroje

1. BaumannN, Pham-DinhD (2001) Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81: 871–927.

2. DietschyJM, TurleySD (2004) Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res 45: 1375–1397.

3. SaherG, BruggerB, Lappe-SiefkeC, MobiusW, TozawaR, et al. (2005) High cholesterol level is essential for myelin membrane growth. Nat Neurosci 8: 468–475.

4. CarsteaED, MorrisJA, ColemanKG, LoftusSK, ZhangD, et al. (1997) Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science 277: 228–231.

5. LoftusSK, MorrisJA, CarsteaED, GuJZ, CummingsC, et al. (1997) Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. Science 277: 232–235.

6. NeufeldEB, WastneyM, PatelS, SureshS, CooneyAM, et al. (1999) The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo. J Biol Chem 274: 9627–9635.

7. HigginsME, DaviesJP, ChenFW, IoannouYA (1999) Niemann-Pick C1 is a late endosome-resident protein that transiently associates with lysosomes and the trans-Golgi network. Mol Genet Metab 68: 1–13.

8. DaviesJP, IoannouYA (2000) Topological analysis of Niemann-Pick C1 protein reveals that the membrane orientation of the putative sterol-sensing domain is identical to those of 3-hydroxy-3-methylglutaryl-CoA reductase and sterol regulatory element binding protein cleavage-activating protein. J Biol Chem 275: 24367–24374.

9. GarverWS, HeidenreichRA, EricksonRP, ThomasMA, WilsonJM (2000) Localization of the murine Niemann-Pick C1 protein to two distinct intracellular compartments. J Lipid Res 41: 673–687.

10. KwonHJ, Abi-MoslehL, WangML, DeisenhoferJ, GoldsteinJL, et al. (2009) Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol. Cell 137: 1213–1224.

11. DeffieuMS, PfefferSR (2011) Niemann-Pick type C 1 function requires lumenal domain residues that mediate cholesterol-dependent NPC2 binding. Proc Natl Acad Sci U S A 108: 18932–18936.

12. KartenB, PeakeKB, VanceJE (2009) Mechanisms and consequences of impaired lipid trafficking in Niemann-Pick type C1-deficient mammalian cells. Biochim Biophys Acta 1791: 659–670.

13. VanierMT (2010) Niemann-Pick disease type C. Orphanet J Rare Dis 5: 16.

14. GermanDC, LiangCL, SongT, YazdaniU, XieC, et al. (2002) Neurodegeneration in the Niemann-Pick C mouse: glial involvement. Neuroscience 109: 437–450.

15. WeintraubH, AbramoviciA, SandbankU, PentchevPG, BradyRO, et al. (1985) Neurological mutation characterized by dysmyelination in NCTR-Balb/C mouse with lysosomal lipid storage disease. J Neurochem 45: 665–672.

16. WeintraubH, AbramoviciA, SandbankU, BoothAD, PentchevPG, et al. (1987) Dysmyelination in NCTR-Balb/C mouse mutant with a lysosomal storage disorder. Morphological survey. Acta Neuropathol 74: 374–381.

17. TakikitaS, FukudaT, MohriI, YagiT, SuzukiK (2004) Perturbed myelination process of premyelinating oligodendrocyte in Niemann-Pick type C mouse. J Neuropathol Exp Neurol 63: 660–673.

18. TrouardTP, HeidenreichRA, SeegerJF, EricksonRP (2005) Diffusion tensor imaging in Niemann-Pick Type C disease. Pediatr Neurol 33: 325–330.

19. WalterfangM, FaheyM, DesmondP, WoodA, SealML, et al. (2010) White and gray matter alterations in adults with Niemann-Pick disease type C: a cross-sectional study. Neurology 75: 49–56.

20. ElrickMJ, PachecoCD, YuT, DadgarN, ShakkottaiVG, et al. (2010) Conditional Niemann-Pick C mice demonstrate cell autonomous Purkinje cell neurodegeneration. Hum Mol Genet 19: 837–847.

21. LaksoM, PichelJG, GormanJR, SauerB, OkamotoY, et al. (1996) Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc Natl Acad Sci U S A 93: 5860–5865.

22. HayashiS, McMahonAP (2002) Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev Biol 244: 305–318.

23. YuT, ShakkottaiVG, ChungC, LiebermanAP (2011) Temporal and cell-specific deletion establishes that neuronal Npc1 deficiency is sufficient to mediate neurodegeneration. Hum Mol Genet 20: 4440–4451.

24. ZhuY, RomeroMI, GhoshP, YeZ, CharnayP, et al. (2001) Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. Genes Dev 15: 859–876.

25. BornigH, GeyerG (1974) Staining of cholesterol with the fluorescent antibiotic “filipin”. Acta Histochem 50: 110–115.

26. SorianoP (1999) Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 21: 70–71.

27. WengQ, ChenY, WangH, XuX, YangB, et al. (2012) Dual-mode modulation of Smad signaling by Smad-interacting protein Sip1 is required for myelination in the central nervous system. Neuron 73: 713–728.

28. CharlesP, HernandezMP, StankoffB, AigrotMS, ColinC, et al. (2000) Negative regulation of central nervous system myelination by polysialylated-neural cell adhesion molecule. Proc Natl Acad Sci U S A 97: 7585–7590.

29. LeeX, YangZ, ShaoZ, RosenbergSS, LevesqueM, et al. (2007) NGF regulates the expression of axonal LINGO-1 to inhibit oligodendrocyte differentiation and myelination. J Neurosci 27: 220–225.

30. WangS, SdrullaAD, diSibioG, BushG, NofzigerD, et al. (1998) Notch receptor activation inhibits oligodendrocyte differentiation. Neuron 21: 63–75.

31. BaudryM, YaoY, SimmonsD, LiuJ, BiX (2003) Postnatal development of inflammation in a murine model of Niemann-Pick type C disease: immunohistochemical observations of microglia and astroglia. Exp Neurol 184: 887–903.

32. UmemoriH, SatoS, YagiT, AizawaS, YamamotoT (1994) Initial events of myelination involve Fyn tyrosine kinase signalling. Nature 367: 572–576.

33. Kramer-AlbersEM, WhiteR (2011) From axon-glial signalling to myelination: the integrating role of oligodendroglial Fyn kinase. Cell Mol Life Sci 68: 2003–2012.

34. Lappe-SiefkeC, GoebbelsS, GravelM, NickschE, LeeJ, et al. (2003) Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 33: 366–374.

35. LiaoG, CheungS, GaleanoJ, JiAX, QinQ, et al. (2009) Allopregnanolone treatment delays cholesterol accumulation and reduces autophagic/lysosomal dysfunction and inflammation in Npc1−/− mouse brain. Brain Res 1270: 140–151.

36. SchullerU, HeineVM, MaoJ, KhoAT, DillonAK, et al. (2008) Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma. Cancer Cell 14: 123–134.

37. KoDC, MilenkovicL, BeierSM, ManuelH, BuchananJ, et al. (2005) Cell-autonomous death of cerebellar purkinje neurons with autophagy in Niemann-Pick type C disease. PLoS Genet 1: e7 doi:10.1371/journal.pgen.0010007.

38. LopezME, KleinAD, DimbilUJ, ScottMP (2011) Anatomically defined neuron-based rescue of neurodegenerative Niemann-Pick type C disorder. J Neurosci 31: 4367–4378.

39. BorbonI, TotenhagenJ, FiorenzaMT, CanteriniS, KeW, et al. (2012) Niemann-Pick C1 mice, a model of “juvenile Alzheimer's disease”, with normal gene expression in neurons and fibrillary astrocytes show long term survival and delayed neurodegeneration. J Alzheimers Dis 30: 875–887.

40. LopezME, KleinAD, HongJ, DimbilUJ, ScottMP (2012) Neuronal and epithelial cell rescue resolves chronic systemic inflammation in the lipid storage disorder Niemann-Pick C. Hum Mol Genet 21: 2946–2960.

41. ChenG, LiHM, ChenYR, GuXS, DuanS (2007) Decreased estradiol release from astrocytes contributes to the neurodegeneration in a mouse model of Niemann-Pick disease type C. Glia 55: 1509–1518.

42. ZhangM, StrnatkaD, DonohueC, HallowsJL, VincentI, et al. (2008) Astrocyte-only Npc1 reduces neuronal cholesterol and triples life span of Npc1−/− mice. J Neurosci Res 86: 2848–2856.

43. EmeryB (2010) Regulation of oligodendrocyte differentiation and myelination. Science 330: 779–782.

44. SperberBR, Boyle-WalshEA, EnglekaMJ, GadueP, PetersonAC, et al. (2001) A unique role for Fyn in CNS myelination. J Neurosci 21: 2039–2047.

45. WakeH, LeePR, FieldsRD (2011) Control of local protein synthesis and initial events in myelination by action potentials. Science 333: 1647–1651.

46. WintersJJ, FergusonCJ, LenkGM, Giger-MateevaVI, ShragerP, et al. (2011) Congenital CNS hypomyelination in the Fig4 null mouse is rescued by neuronal expression of the PI(3,5)P(2) phosphatase Fig4. J Neurosci 31: 17736–17751.

47. VerheijenMH, CamargoN, VerdierV, NadraK, de Preux CharlesAS, et al. (2009) SCAP is required for timely and proper myelin membrane synthesis. Proc Natl Acad Sci U S A 106: 21383–21388.

48. SunX, MarksDL, ParkWD, WheatleyCL, PuriV, et al. (2001) Niemann-Pick C variant detection by altered sphingolipid trafficking and correlation with mutations within a specific domain of NPC1. Am J Hum Genet 68: 1361–1372.

49. KartenB, VanceDE, CampenotRB, VanceJE (2002) Cholesterol accumulates in cell bodies, but is decreased in distal axons, of Niemann-Pick C1-deficient neurons. J Neurochem 83: 1154–1163.

50. WojtanikKM, LiscumL (2003) The transport of low density lipoprotein-derived cholesterol to the plasma membrane is defective in NPC1 cells. J Biol Chem 278: 14850–14856.

51. HawesCM, WiemerH, KruegerSR, KartenB (2010) Pre-synaptic defects of NPC1-deficient hippocampal neurons are not directly related to plasma membrane cholesterol. J Neurochem 114: 311–322.

52. YazawaI, GiassonBI, SasakiR, ZhangB, JoyceS, et al. (2005) Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration. Neuron 45: 847–859.

53. LeeY, MorrisonBM, LiY, LengacherS, FarahMH, et al. (2012) Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487: 443–448.

54. RichardsonWD, KessarisN, PringleN (2006) Oligodendrocyte wars. Nat Rev Neurosci 7: 11–18.